María Álvarez

María Álvarez

Auto-generated profile, based on publicly available information

María Álvarez

Medtronic Ibérica, S.A., Madrid, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Health Economics Review
Verified
Journal Article
Open access
PDF file
BFBlas Flor-Lorente
Blas Flor-Lorente
JNJosé Francisco Noguera-Aguilar
José Francisco Noguera-Aguilar
SDSalvadora Delgado-Rivilla
Salvadora Delgado-Rivilla
JGJosé María García-González
José María García-González
MRMarcos Rodriguez-Martín
Marcos Rodriguez-Martín
MÁMaría Álvarez
María Álvarez
Objective: To determine the economic impact of the incremental consumption of resources for the diagnosis and treatment of anastomotic leak (AL) in patients after resection with anastomosis for colorectal cancer compared to patients without AL on the Spanish health system. Method: This study included a literature review with parameters validated by experts and the development of a cost analysis model to estimate the incremental resource consumption of patients with AL versus those without. The patients were divided into three groups: 1) colon cancer (CC) with resection, anastomosis and AL; 2) rectal cancer (RC) with resection, anastomosis without protective stoma and AL; and 3) RC with resection, anastomosis with protective stoma and AL. Results: The average total incremental cost per patient was €38,819 and €32,599 for CC and RC, respectively. The cost of AL diagnosis per patient was €1018 (CC) and €1030 (RC). The cost of AL treatment per patient in Group 1 ranged from €13,753 (type B) to €44,985 (type C + stoma), that in Group 2 ranged from €7348 (type A) to €44,398 (type C + stoma), and that in Group 3 ranged from €6197 (type A) to €34,414 (type C). Hospital stays represented the highest cost for all groups. In RC, protective stoma was found to minimize the economic consequences of AL. Conclusions: The appearance of AL generates a considerable increase in the consumption of health resources, mainly due to an increase in hospital stays. The more complex the AL, the higher the cost associated with its treatment. Interest of the study: it is the first cost-analysis study of AL after CR surgery based on prospective, observational and multicenter studies, with a clear, accepted and uniform definition of AL and estimated over a period of 30 days.

25 April 2020 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
OGOn behalf of the VALIOSA study group
On behalf of the VALIOSA study group
MDMiguel A. Ruiz Díaz
Miguel A. Ruiz Díaz
MGMarta Egea García
Marta Egea García
RARoberto Muñoz Aguilera
Roberto Muñoz Aguilera
XPXavier Viñolas Prat
Xavier Viñolas Prat
JFJosé Martínez Ferrer
José Martínez Ferrer
Background: Remote monitoring of cardiac implantable electronic devices (CIEDs) has demonstrated substantial benefits. Treatment guidelines have therefore endorsed its use and is being increasingly adopted in the clinical setting, but the level of satisfaction they convey remains still unknown. We developed and validated a questionnaire to measure patient satisfaction with remote monitoring using Medtronic CareLink® Network and assessed its internal reliability and dimensional validity. Methods: After a thorough literature review, cognitive debriefing of 18 patients, and an expert panel discussion, a 30-item instrument was proposed and grouped into 5 dimensions (items): 1- Information on cardiac condition (3), 2- Device convenience (3), 3- Transmission process (6), 4- Satisfaction with medical monitoring (8), and 5- General opinions (10). Correlation with the visual analog scale (VAS), overall health related quality of life (HRQoL) measured by the EuroQoL-5D accompanied by the VAS as well as with the Medical Outcomes Study (MOS) SF-36 were assessed. Psychometric properties, exploratory factor analysis and a second order confirmatory factor analysis (a hierarchical CFA with a general common factor explaining the relations between the first order common factors, See Figure 1) were estimated. Models were assessed based on item loading size, sign and statistical significance, and goodness-of-fit statistics. Results: A total of 186 patients (77% male) with a mean age of 66.03 (SD = 13.94) years were assessed. 48% had implantable cardioverter-defibrillators, 24% had pacemakers, and 29% had cardiac resynchronization therapy devices. An overall Cronbach’s α = 0.893 was achieved, with acceptable reliabilities for isolated dimensions. Correlations with corresponding VAS scales were meaningful and significant (p < 0.01). The second order factor solution yielded good goodness-of-fit indexes (χ2/df = 1.44, CFI = 0.96, TLI = 0.95, RMSEA = 0.05). Satisfaction with remote monitoring was not related to HRQoL (r < 0.05), except for the correlation between the SF-36 mental component and the information on cardiac condition dimension (r = 0.263, p < 0.001). Conclusions: The 30-item questionnaire showed good reliability and validity to assess satisfaction with remote monitoring in patients with CIEDs.

15 April 2023 in Pain Practice
Verified
Journal Article
Open access
JCJosé Luis de la Calle
José Luis de la Calle
DADavid Abejón
David Abejón
AVANGELES Canos Verdecho
ANGELES Canos Verdecho
JCJosé Cid
José Cid
PPPablo López Pais
Pablo López Pais
MÁMaría Álvarez
María Álvarez
Objective: To determine, using the Delphi method, standardized recommendations for the follow‐up of patients undergoing an interventional procedure for the treatment of chronic pain in Spain.Methods: First, a systematic literature review was performed to identify the literature on the management of patients with chronic pain undergoing interventional techniques; subsequently, a two‐round Delphi survey with 108 questions was conducted. The questionnaire was validated by a Scientific Committee (5 experts) and sent to 47 experts specialized in chronic pain. “Consensus” or “intermediate consensus” was determined when ≥ 75% or < 75% to ≥ 65% of the experts selected the same answer for each item, respectively. Then, a face‐to‐face deliberation process was held with the Scientific Committee to analyze and discuss the results.Results: The questionnaire was completed by 24 panelists (51%). Consensus was reached on 88.4% of the questions. The panelists identified pain, drug consumption, and quality of life as essential variables in the follow‐up of patients with chronic pain. Consensus was reached on most of the scales/questionnaires to be used in measuring outcomes during follow‐up, except for psychological status. Regarding the follow‐up frequency, in radicular spinal chronic pain, a consensus was reached on the first visit 1–2 months after the intervention, during the first year, at 1, 3, 6, and 12 months, and then every 6 months thereafter. For non‐radicular spinal chronic pain, the first visit 1–2 months after surgery was agreed upon, however, there was no consensus on follow‐up during the first year. For non‐spinal chronic pain, consensus was reached regarding the first visit at 1–2 months after surgery and during the first year at 1, 3, 6, and 12 months. No consensus was reached on follow‐up frequency for oncological chronic pain. After receiving a permanent neurostimulator implant for chronic pain, the first visit was agreed upon at 1–3 weeks, during the first year, at 2 weeks, 1, 3, 6, and 12 months, and after, every 6 months. For intrathecal infusion, it was agreed that the first visit should occur during the first month, and thereafter whenever the pump requires a refill.Conclusions: These findings provide recommendations in relation to the frequency of follow‐up and the scales to be used with chronic pain patients undergoing interventional techniques in Spain.

1 August 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
CPConcepción Pérez-Hernández
Concepción Pérez-Hernández
TQTeresa Quintanar
Teresa Quintanar
CGCarmen García
Carmen García
MCMiguel Ángel Cuervo
Miguel Ángel Cuervo
MGMaría Jesús Goberna
María Jesús Goberna
IPIsaac Peña
Isaac Peña
A consensus is needed among healthcare professionals involved in easing oncological pain in patients who are suitable candidates for intrathecal therapy. A Delphi consultation was conducted, guided by a multidisciplinary scientific committee. The 18-item study questionnaire was designed based on a literature review together with a discussion group. The first-round questionnaire assessed experts’ opinion of the current general practice, as well as their recommendation and treatment feasibility in the near future (2–3-year period) using a 9-point Likert scale. Items for which consensus was not achieved were included in a second round. Consensus was defined as ≥75% agreement (1–3 or 7–9). A total of 67 panelists (response rate: 63.2%) and 62 (92.5%) answered the first and second Delphi rounds, respectively. The participants were healthcare professionals from multiple medical disciplines who had an average of 17.6 (7.8) years of professional experience. A consensus was achieved on the recommendations (100%). The actions considered feasible to implement in the short term included effective multidisciplinary coordination, improvement in communication among the parties, and an assessment of patient satisfaction. Efforts should focus on overcoming the barriers identified, eventually leading to the provision of more comprehensive care and consideration of the patient’s perspective.

4 May 2026 in Journal of Robotic Surgery
Verified
Journal Article
Open access
RLRubén Martín Láez
Rubén Martín Láez
FWFernando Álvarez-Sala Walther
Fernando Álvarez-Sala Walther
JMJulen Monje
Julen Monje
MÁMaría Álvarez
María Álvarez
MZMehdi Zahra
Mehdi Zahra
JAJose F Alen
Jose F Alen
Robot-assisted spine surgery (RASS) enhances procedural accuracy and reproducibility by ensuring full adherence to preoperative surgical plans. However, its widespread adoption remains limited by the need for a substantial upfront investment. In this study, the economic impact of spinal procedures performed under the guidance of the Mazor™ robotic system was compared with that of conventional techniques from an advanced Spanish hospital perspective. A 10-year budget impact analysis was conducted. The target population included all spinal surgeries potentially suitable for robot assistance, estimated from published data and expert input. Two scenarios were compared: a baseline scenario without Mazor™ and a progressive Mazor™ adoption scenario. Unit costs (€, 2025), obtained from Spanish sources, were applied to components of health care resource consumption. Model inputs and assumptions were validated by a panel of Spanish experts. A deterministic one-way sensitivity analysis (OWSA) was performed to assess the robustness of the results. The number of RASS-eligible patients increased from 213 to 330 annually over 10 years (2,673 total). The mean cost per patient was €10,093 for conventional surgery and €9,082 for RASS, generating average savings of €1,011 per patient. Savings were driven mainly by reductions in the length of hospital stay (€1,523), revision surgeries (€793), and complications (€261), outweighing the Mazor™ acquisition cost. Over the 10-year horizon, cumulative savings reached €2.54 million, achieving full capital investment recovery within 3.83 years. OWSA confirmed the robustness of these findings. From an advanced Spanish hospital perspective, the initial investment in RASS is recouped within four years, supporting its financial sustainability and long-term economic advantage over conventional spinal surgery.